HomeCompareMNKKQ vs ADC

MNKKQ vs ADC: Dividend Comparison 2026

MNKKQ yields 10000.00% · ADC yields 4.11%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MNKKQ wins by $55137509079256512.00M in total portfolio value
10 years
MNKKQ
MNKKQ
● Live price
10000.00%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$55137509079256512.00M
Annual income
$54,073,795,673,722,890,000,000.00
Full MNKKQ calculator →
ADC
Agree Realty Corporation
● Live price
4.11%
Share price
$75.38
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$176.9K
Annual income
$79,647.25
Full ADC calculator →

Portfolio growth — MNKKQ vs ADC

📍 MNKKQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMNKKQADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MNKKQ + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MNKKQ pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MNKKQ
Annual income on $10K today (after 15% tax)
$850,000.00/yr
After 10yr DRIP, annual income (after tax)
$45,962,726,322,664,450,000,000.00/yr
ADC
Annual income on $10K today (after 15% tax)
$349.45/yr
After 10yr DRIP, annual income (after tax)
$67,700.16/yr
At 15% tax rate, MNKKQ beats the other by $45,962,726,322,664,450,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MNKKQ + ADC for your $10,000?

MNKKQ: 50%ADC: 50%
100% ADC50/50100% MNKKQ
Portfolio after 10yr
$27568754539628256.00M
Annual income
$27,036,897,836,861,443,000,000.00/yr
Blended yield
98.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

MNKKQ
Analyst Ratings
1
Hold
2
Sell
Consensus: Sell
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+7.5% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MNKKQ buys
0
ADC buys
0
No recent congressional trades found for MNKKQ or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMNKKQADC
Forward yield10000.00%4.11%
Annual dividend / share$2.00$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$55137509079256512.00M$176.9K
Annual income after 10y$54,073,795,673,722,890,000,000.00$79,647.25
Total dividends collected$55066727460582336.00M$154.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusSellBuy

Year-by-year: MNKKQ vs ADC ($10,000, DRIP)

YearMNKKQ PortfolioMNKKQ Income/yrADC PortfolioADC Income/yrGap
1← crossover$1,010,700$1,000,000.00$10,987$577.21+$999.7KMNKKQ
2$95,539,393$94,457,943.93$12,293$855.34+$95.53MMNKKQ
3$8,447,007,736$8,344,780,585.66$14,088$1,290.70+$8446.99MMNKKQ
4$698,565,746,383$689,527,448,105.17$16,660$1,994.91+$698565.73MMNKKQ
5$54,040,711,670,213$53,293,246,321,583.74$20,525$3,181.85+$54040711.65MMNKKQ
6$3,910,851,616,519,516$3,853,028,055,032,387.00$26,654$5,286.90+$3910851616.49MMNKKQ
7$264,781,167,546,477,440$260,596,556,316,801,570.00$37,006$9,259.47+$264781167546.44MMNKKQ
8$16,772,556,223,821,672,000$16,489,240,374,546,942,000.00$55,862$17,338.74+$16772556223821.62MMNKKQ
9$994,124,678,068,810,000,000$976,178,042,909,320,800,000.00$93,452$35,300.32+$994124678068809.88MMNKKQ
10$55,137,509,079,256,515,000,000$54,073,795,673,722,890,000,000.00$176,931$79,647.25+$55137509079256512.00MMNKKQ

MNKKQ vs ADC: Complete Analysis 2026

MNKKQStock

Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands and Specialty Generics. The company markets branded pharmaceutical products for autoimmune and rare diseases in the areas of neurology, rheumatology, nephrology, ophthalmology, pulmonology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes; and gastrointestinal products. It offers Acthar Gel, a repository corticotropin injection for rheumatoid arthritis, infantile spasms, systemic lupus erythematosus, multiple sclerosis, systemic dermatomyositis, symptomatic sarcoidosis, severe acute and chronic allergic, and inflammatory diseases; INOmax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Therakos photopheresis, an immunotherapy treatment platform; Amitiza for constipation; and StrataGraft for the treatment of adults with deep partial-thickness burns. The company is also developing Terlipressin for the treatment of hepatorenal syndrome; and SLN 501 is a ribonucleic acid silencing therap. In addition, it provides specialty generic drugs and active pharmaceutical ingredients. The company markets its branded products to physicians, respiratory therapists, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. Mallinckrodt plc has collaboration with Silence Therapeutics plc to develop and commercialize ribonucleic acid interference drug targets. The company was founded in 1867 and is based in Dublin, Ireland. On October 12, 2020, Mallinckrodt plc, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Full MNKKQ Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this MNKKQ vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MNKKQ vs SCHDMNKKQ vs JEPIMNKKQ vs OMNKKQ vs KOMNKKQ vs MAINMNKKQ vs NNNMNKKQ vs EPRTMNKKQ vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.